Everyone who has money in this stock should have known you could lose every penny. That's it. So with that mentality why wouldn't you stay in for the real catalyst, which is ADCOM. Yes, the papers were bad, worse than bad. But guess what, this is not an FDA panel voting, but an advisory panel. They could still vote 'yes'. I will hold and wait and see...I am in this all the way...way not? Losing in this stock doesn't surprise me, but it would kill me to sell before ADCOM only to see a positive vote.